Targeted therapies make room, anti-CD79b agents are coming.
Journal: 2019/May - The Lancet Oncology
ISSN: 1474-5488
Relations:
Genes
(1)
Affiliates
(1)
Similar articles
Articles by the same authors
Discussion board
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.